文献速递呼吸道感染呼吸危重症与机械通气

流感或COVID-19相关肺曲霉病中肺上皮与髓系先天免疫的作用:一项观察性研究

Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study.
PubMed 文献 · Lancet Respir Med · 2022-08-24

该观察性研究回顾性纳入比利时鲁汶大学医院ICU中因重症流感或COVID-19需通气的患者,比较合并或不合并曲霉病者支气管肺泡灌洗液的基因表达和蛋白水平。发现IAPA和CAPA患者存在抗真菌免疫三重缺陷:上皮屏障受损、吞噬杀伤孢子能力下降、中性粒细胞破坏菌丝能力减弱,且IFNγ信号下调。提示辅助IFNγ治疗值得研究。

要点

  • IAPA和CAPA患者下调抗真菌效应基因及参与孢子调理、识别和杀伤的基因。
  • CAPA患者中性粒细胞分数显著低于单纯COVID-19患者。
  • IAPA和CAPA患者IFNγ信号通路上调受损,纤维化相关生长因子升高。

核心结论

  • IAPA和CAPA存在三重抗真菌免疫缺陷:上皮屏障完整性破坏、吞噬杀伤孢子能力下降、中性粒细胞破坏菌丝能力减弱。
  • IAPA和CAPA患者IFNγ信号下调,辅助IFNγ治疗值得进一步研究。

研究设计与样本

  • 观察性研究,回顾性纳入2011年1月1日至2021年3月31日比利时鲁汶大学医院ICU需无创或有创通气的重症流感或COVID-19患者,其支气管肺泡灌洗液样本可自医院生物样本库获取。
  • 纳入166例患者:40例IAPA、52例单纯流感、33例CAPA、41例单纯COVID-19;对134例样本行nCounter基因表达分析,162例行蛋白分析,130例行两者。
  • 另收集IAPA或CAPA合并侵袭性曲霉气管支气管炎患者的体内气管支气管活检样本,行RNAScope和GeoMx空间转录组学分析。

主要发现

  • IAPA患者和程度较轻的CAPA患者中,与抗真菌效应功能相关的基因表达下调。
  • 与单纯流感相比,IAPA患者中多个编码参与孢子调理、识别和杀伤蛋白的基因表达下调;与单纯COVID-19相比,CAPA患者中同样下调。
  • 多个与LC3相关吞噬、自噬或两者相关的基因存在差异表达。
  • CAPA患者中性粒细胞分数显著低于单纯COVID-19患者。
  • 与单纯流感或单纯COVID-19相比,IAPA或CAPA患者IFNγ信号下调;IAPA和CAPA患者支气管肺泡灌洗液中多种纤维化相关生长因子浓度显著升高。

临床怎么用

  • 应关注IAPA和CAPA患者抗真菌免疫三重缺陷,尤其是中性粒细胞功能和IFNγ信号。
  • 辅助IFNγ治疗IAPA和CAPA的潜力值得进一步临床研究。

局限性

  • 为回顾性观察性研究,样本来自单一中心生物样本库及部分外院活检。
  • 活检样本仅来自4例患者(2例IAPA合并侵袭性曲霉气管支气管炎,2例CAPA合并侵袭性曲霉气管支气管炎),空间转录组学结果代表性有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Influenza-associated pulmonary aspergillosis (IAPA) and COVID-19-associated pulmonary aspergillosis (CAPA) affect about 15% of critically ill patients with influenza or COVID-19, respectively. These viral-fungal coinfections are difficult to diagnose and are associated with increased mortality, but data on their pathophysiology are scarce. We aimed to explore the role of lung epithelial and myeloid innate immunity in patients with IAPA or CAPA. METHODS: In this observational study, we retrospectively recruited patients who had been admitted to the intensive care unit (ICU) of University Hospitals Leuven, Belgium, requiring non-invasive or invasive ventilation because of severe influenza or COVID-19, with or without aspergillosis, between Jan 1, 2011, and March 31, 2021, whose bronchoalveolar lavage samples were available at the hospital biobank. Additionally, biobanked in vivo tracheobronchial biopsy samples from patients with IAPA or CAPA and invasive Aspergillus tracheobronchitis admitted to ICUs requiring invasive ventilation between the same dates were collected from University Hospitals Leuven, Hospital Network Antwerp (Belgium), and Amiens-Picardie University Hospital (France). We did nCounter gene expression analysis of 755 genes linked to myeloid innate immunity and protein analysis of 47 cytokines, chemokines, and growth factors on the bronchoalveolar lavage samples. Gene expression data were used to infer cell fractions by use of CIBERSORTx, to perform hypergeometric enrichment pathway analysis and gene set enrichment analysis, and to calculate pathway module scores for the IL-1β, TNF-α, type I IFN, and type II IFN (IFNγ) pathways. We did RNAScope targeting influenza virus or SARS-CoV-2 RNA and GeoMx spatial transcriptomics on the tracheobronchial biopsy samples. FINDINGS: Biobanked bronchoalveolar lavage samples were retrieved from 166 eligible patients, of whom 40 had IAPA, 52 had influenza without aspergillosis, 33 had CAPA, and 41 had COVID-19 without aspergillosis. We did nCounter gene expression analysis on bronchoalveolar lavage samples from 134 patients, protein analysis on samples from 162 patients, and both types of analysis on samples from 130 patients. We performed RNAScope and spatial transcriptomics on the tracheobronchial biopsy samples from two patients with IAPA plus invasive Aspergillus tracheobronchitis and two patients with CAPA plus invasive Aspergillus tracheobronchitis. We observed a downregulation of genes associated with antifungal effector functions in patients with IAPA and, to a lesser extent, in patients with CAPA. We found a downregulated expression of several genes encoding proteins with functions in the opsonisation, recognition, and killing of conidia in patients with IAPA versus influenza only and in patients with CAPA versus COVID-19 only. Several genes related to LC3-associated phagocytosis, autophagy, or both were differentially expressed. Patients with CAPA had significantly lower neutrophil cell fractions than did patients with COVID-19 only. Patients with IAPA or CAPA had downregulated IFNγ signalling compared with patients with influenza only or COVID-19 only, respectively. The concentrations of several fibrosis-related growth factors were significantly elevated in the bronchoalveolar lavage fluid from patients with IAPA versus influenza only and from patients with CAPA versus COVID-19 only. In one patient with CAPA, we visualised an active or very recent SARS-CoV-2 infection disrupting the epithelial barrier, facilitating tissue-invasive aspergillosis. INTERPRETATION: Our results reveal a three-level breach in antifungal immunity in IAPA and CAPA, affecting the integrity of the epithelial barrier, the capacity to phagocytise and kill Aspergillus spores, and the ability to destroy Aspergillus hyphae, which is mainly mediated by neutrophils. The potential of adjuvant IFNγ in the treatment of IAPA and CAPA should be investigated. FUNDING: Research Foundation Flanders, Coronafonds, the Max Planck Society, the Fundação para a Ciência e a Tecnologia, the European Regional Development Fund, "la Caixa" Foundation, and Horizon 2020.

来源:Lancet Respir Med,查看原文。版权归原作者所有。

引用

  1. Feys S, Gonçalves SM, Khan M, et al. Lung epithelial and myeloid innate immunity in influenza-associated or COVID-19-associated pulmonary aspergillosis: an observational study. Lancet Respir Med. 2022. PMID: 36029799. doi:10.1016/S2213-2600(22)00259-4

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。